中药周期疗法治疗乳腺增生病的系统评价  

Systimetic Review of Chinese Medicine Periodic Treatment for Hyperplasia of Mammary Glands

作　　者：苏群善[1] 刘晓雁[1] 钟少文[1] 

机构地区：[1]广东省中医院,广东广州510120

出　　处：《中国中医药信息杂志》2011年第11期31-33,共3页Chinese Journal of Information on Traditional Chinese Medicine

基　　金：中医药行业科研专项(200707004)

摘　　要：目的评价中药周期疗法治疗乳腺增生病的有效性。方法检索中国生物医学文献数据库、中国期刊全文数据库、中文科技期刊数据库,收集中药周期疗法治疗乳腺增生病的随机对照试验。由2名研究者独立依据Cochrane Reviewers Handbook 4.2.2随机对照试验的4条质量评价标准评价所纳入研究的文献质量,对符合纳入标准的研究采用Cochrane collaboration’s RevMan 5.0.18 Meta分析。结果纳入9个随机对照试验900例乳腺增生病患者。与一方通治的中药治疗方法比较,中药周期疗法治疗乳腺增生病可提高有效率。结论现有的有效数据表明,中药周期疗法治疗乳腺增生病优于不分周期的中药治疗,但受纳入研究文献的数量和质量限制,目前还不足以得出完全肯定的结论,尚需更多高质量的随机双盲对照试验加以证实。Objective To assess the effectiveness of Chinese medicine periodic treatment for hyperplasia of mammary glands.Methods By searching in the major databases of CBM,CNKI and VIP,we searched the randomized controlled trials of Chinese medicine periodic treatment for hyperplasia of mammary glands.The quality of the included studies was evaluated by Cochrane reviewer＇s handbook 4.2.2 recommended standard and the data were analyzed by Cochrane collaboration＇s RevMan 5.0.18.Results Nine randomized controlled trials involving totally 900 patients were collected.Chinese medicine periodic treatment can improve the efficacy rate of hyperplasia of mammary glands comparing with general treatment by one prescription.Conclusion Available evidence shows that Chinese medicine periodic treatment is more effective than aperiodic treatment.However,because of the limited of the quality and quantity of the included studies,to confirm the efficacy of Chinese medicine periodic treatment for hyperplasia of mammary glands,more high-quality randomized,double-blind,placebo-controlled trials will be needed.

关 键 词：中药 周期疗法 乳腺增生 随机对照试验 系统评价 

分 类 号：R2-05[医药卫生—中医学] R269.588.2